ASHLEY SENTELL: Open Payments
NPI 1891396800 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 43 payments from 15 companies in 2025. Trend: 2023 $367 · 2024 $470 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $160 |
| ABBVIE INC. | 8 | $151 |
| ARGENX US, INC. | 4 | $83 |
| Neurelis, Inc. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Eisai Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $40 |
| PFIZER INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: Nayzilam, VALTOCO, VYVGART HYTRULO, PONVORY, UBRELVY, QULIPTA, BOTOX, Leqembi.
Industry payments across MI — which companies pay providers there.
